On February 27, 2023 Veracyte, Inc. (Nasdaq: VCYT) reported that Marc Stapley, chief executive officer, and Rebecca Chambers, chief financial officer, will participate in two upcoming investor conferences (Press release, Veracyte, FEB 27, 2023, View Source [SID1234627751]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Cowen’s 43rd Annual Health Care Conference – Boston, MA
Presentation on March 7th at 9:50 a.m. Eastern Time
KeyBanc Virtual Life Sciences & MedTech Investor Forum
Fireside Chat on March 21st at 3:45 p.m. Eastern Time
Live audio webcasts of the company’s presentations will be available by visiting Veracyte’s website at View Source A replay of the webcasts will be available for 90 days following the conclusion of the live presentation broadcast.